The natural history of AB accumulation in preclinical AD
The natural history of AB accumulation in preclinical AD
批准号:
8287320
负责人:
JOHN MORRIS
金额:
$55.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2016-08-31
关键词:
APP-PS1AdultAdult ChildrenAffectAgeAge-YearsAllelesAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAtrophicBindingBiologicalBiological MarkersBiometryBrainCerebrospinal FluidCerebrumCessation of lifeChronologyClinicalCognitiveConduct Clinical TrialsDataData AnalysesDepositionDerivation procedureFosteringFunctional disorderFundingFutureGenotypeGrowthHistologicImageImpaired cognitionIncidenceIndividualInstructionInterventionKnowledgeLifeMeasuresMediatingNatural HistoryOccupationsParticipantPeptidesPerformancePersonsPittsburgh Compound-BPositioning AttributePositron-Emission TomographyPreventionPrimary PreventionProgram Research Project GrantsPropertyRecording of previous eventsResearchResourcesSample SizeScanningSenile PlaquesSignal TransductionSourceStagingTestingTimeTracerTransgenic Micebasebenzothiazolebrain volumecognitive reservecohortdata managementdesignhigh riskin vivomiddle ageneuropathologypre-clinical
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project 1 aims to characterize the accumulation of fibrillar cerebral amyloid-beta (AP) over the age
range from the time of onset of Ap deposits to the time when Ap levels approximate those of symptomatic
Alzheimer's disease (AD). Project 1 proposes a longitudinal [^^C] PIB imaging study in the cohort of the
Adult Children Study (ACS). PET PIB scans will be done on ail ACS participants every two years. The
data to be obtained will greatly expand knowledge about preclinical AD and the clinical correlates of Ap
accumulation. The long term objective of this effort is to obtain data that will facilitate and foster the design
and conduct of clinical trials of anti-Ap therapies for the primary prevention of symptomatic AD. In
particular, it aims to help determine the optimal time for intervention in such a trial.
Specific Aims are:
1. Obtain longitudinal ["C] PIB PET scans every 2 years in cognitively normal ACS participants to identify
the conversion rate from no or minimal fibrillar Ajj deposition to appreciable AP accumulation, defined
by mean cortical binding potential (MCBP) for PIB >0.18, and determine whether this rate is affected
by age, APOE genotype, and parental history of AD.
2. Determine the rate and trajectory of change in Ap accumulation in ACS participants, both those with
appreciable Ap deposits at their baseline [^^C] PIB PET scan and those lacking Ap deposits at
baseline.
3. Examine associations and interactions of cognitive and brain reserve variables (e.g., normalized whole
brain volume; regional atrophy; occupation; educational attainment) with longitudinal cognitive
performance, obtained in the Clinical Core, in participants with and without Ap accumulation.
4. Correlate findings from Project 1 with appropriate data from Projects 2, 3, and 4 and utilize the
Administration (e.g., budgetary oversight), Clinical (e.g., source of participants; longitudinal clinical and
cognitive data), Biomarker (e.g., cerebrospinal fluid levels of AP42 in Project 1 participants imaged for Ap
deposits), and Data Management and Biostatistics (e.g., data analyses) Cores of this program project
grant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing Participation of Historically Minoritized Groups in Alzheimer Disease and Related Dementias Research
-
批准号:10752461
-
项目类别:
-
资助金额:$4.96万
-
财政年份:2023
-
负责人:JOHN MORRIS
-
依托单位:
Administration Core
-
批准号:10164694
-
项目类别:
-
资助金额:$66.8万
-
财政年份:2020
-
负责人:JOHN MORRIS
-
依托单位:
Clinical Core
-
批准号:10622636
-
项目类别:
-
资助金额:$150.06万
-
财政年份:2020
-
负责人:JOHN MORRIS
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:10164693
-
项目类别:
-
资助金额:$306.61万
-
财政年份:2020
-
负责人:JOHN MORRIS
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:9919042
-
项目类别:
-
资助金额:$306.49万
-
财政年份:2020
-
负责人:JOHN MORRIS
-
依托单位:
Clinical Core
-
批准号:10164695
-
项目类别:
-
资助金额:$68.0万
-
财政年份:2020
-
负责人:JOHN MORRIS
-
依托单位:
AFRICAN AMERICAN PARTICIPATION IN AD RESEARCH: EFFECTIVE STRATEGIES
-
批准号:9543046
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:JOHN MORRIS
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8374624
-
项目类别:
-
资助金额:$15.01万
-
财政年份:2012
-
负责人:JOHN MORRIS
-
依托单位:
CLINICAL
-
批准号:8374625
-
项目类别:
-
资助金额:$53.13万
-
财政年份:2012
-
负责人:JOHN MORRIS
-
依托单位:
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA
-
批准号:8374633
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2012
-
负责人:JOHN MORRIS
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8215299
-
项目类别:
-
资助金额:$11.21万
-
财政年份:2011
-
负责人:JOHN MORRIS
-
依托单位:
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA
-
批准号:8215304
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2011
-
负责人:JOHN MORRIS
-
依托单位:
CLINICAL
-
批准号:8215300
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2011
-
负责人:JOHN MORRIS
-
依托单位:
Administration Core
-
批准号:8287315
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2011
-
负责人:JOHN MORRIS
-
依托单位:
Clinical
-
批准号:8287316
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2011
-
负责人:JOHN MORRIS
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8040955
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2010
-
负责人:JOHN MORRIS
-
依托单位:
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA
-
批准号:8040960
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2010
-
负责人:JOHN MORRIS
-
依托单位:
CLINICAL
-
批准号:8040956
-
项目类别:
-
资助金额:$67.7万
-
财政年份:2010
-
负责人:JOHN MORRIS
-
依托单位:
HEALTHY AGING AND SENILE DEMENTIA
-
批准号:7919092
-
项目类别:
-
资助金额:$14.36万
-
财政年份:2009
-
负责人:JOHN MORRIS
-
依托单位:
PRECLINICAL ALZHEMER'S DISEASE PREDICTS POST-STROKE DEMENTIA
-
批准号:7578737
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2009
-
负责人:JOHN MORRIS
-
依托单位:
海外基金